Clinical Trial Update: Hyperfractionated Dual Equivalent Fractionated Radiation Therapy [NA]

View source ↗

Summary

A clinical trial at Yale University is evaluating a hyperfractionated dual equivalent fractionated radiation therapy approach for Diffuse Large B-Cell Lymphoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Yale University | Conditions: Diffuse Large B-Cell Lymphoma | NA | Status: RECRUITING